Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cardlytics ( (CDLX) ) has provided an announcement.
On December 3, 2025, Cardlytics announced that its Chief Financial Officer, Alexis DeSieno, plans to resign by March 6, 2026, or upon the appointment of her successor. Her resignation is not due to any disagreements with the company, and she will continue in an advisory role until her departure. The company has expressed gratitude for her contributions, particularly in improving the balance sheet and optimizing the cost structure.
The most recent analyst rating on (CDLX) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Cardlytics stock, see the CDLX Stock Forecast page.
Spark’s Take on CDLX Stock
According to Spark, TipRanks’ AI Analyst, CDLX is a Underperform.
Cardlytics’ overall stock score is primarily impacted by its poor financial performance and bearish technical indicators. The company’s high leverage and declining revenue present significant risks. While strategic initiatives and cost reductions offer some hope, the negative valuation metrics and oversold technical conditions weigh heavily on the stock’s attractiveness.
To see Spark’s full report on CDLX stock, click here.
More about Cardlytics
Average Trading Volume: 5,040,601
Technical Sentiment Signal: Sell
Current Market Cap: $65.41M
For detailed information about CDLX stock, go to TipRanks’ Stock Analysis page.